2026/27 flu immunisation programme amendments
Amended 2026/27 flu letter: community pharmacies can vaccinate eligible children, including 2 and 3-year-olds, from 1 October.
Category Vaccinations & screening
Showing: Guidance Everything, including news and events
Topics:Collective action & GPCContracts & fundingPCNs & neighbourhoodsVaccinations & screeningPrescribing & medicinesReferrals & hospital servicesPublic healthIT, data & cyber securityWorkforce & employmentCQC, regulation & governancePCSE & patient registrationFees & non-NHS workPremises & estatesWellbeing & supportBLMC news
Prostate cancer screening programme: Q&A for practices
Following ministers' acceptance of the National Screening Committee's recommendation on prostate screening, a Q&A document has been produced for GP practices.
MMR vaccination for practice staff, until 30 September 2026
Practices may vaccinate eligible staff registered elsewhere with MMR under INT until 30 September 2026. No item of service fee applies, but CNSGP indemnity covers it.
Webinar: preventing and responding to measles outbreaks, 17 June
National NHS/UKHSA webinar on measles epidemiology, inequalities in uptake and evidence-based approaches to outbreaks.
Survey on patients’ access needs for vaccination services
A short survey for GP and pharmacy vaccination teams on patients' access needs, such as wheelchair access, and how providers support them.
COVID-19 spring campaign: final push
The ICB thanked practices for the spring COVID-19 campaign (47,355 vaccinated so far) and asked for a final push to reach eligible patients.
Immunisations and vaccination QI forum, 25 June
An online quality improvement forum for general practice on the vaccination programme, 12:30pm on Teams.
Flu vaccine uptake among frontline healthcare workers, 2025/26
A national report on flu vaccine uptake among frontline healthcare workers in the 2025/26 programme.
Lung cancer screening awareness session, 9 June
A one-hour Project ECHO session on the NHS lung cancer screening programme, aimed at increasing uptake among underserved groups.
Spring 2026 COVID-19 Vaccination Programme: Nuvaxovid JN.1 allocation now available
Nuvaxovid JN.1 allocations available, but not for allergy clinics or people who have reacted to COVID-19 vaccines.